If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
4,714.00    -186.00 (-3.80%)
Bid:
4,708.00
Ask:
4,718.00
Spread: 10.00 (0.212%)
Market Cap: £3.43b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

13 Oct 2011 11:05

RNS Number : 1203Q
Renishaw PLC
13 October 2011
 



 

Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2011. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

Revenue for the three months to 30th September 2011 was £70.5m, an increase of 15.0% over the £61.3m for the first quarter of the previous year but below planned-for revenue. The previous year has been restated for the inclusion of Measurement Devices Limited from July 2010, which was initially accounted for as an associate company.

 

Geographically, Europe reported growth of 26% over the comparable period last year and the Americas a growth of 21%. The Far East, an area of significant growth last year, showed revenue for this quarter at a similar level to the corresponding quarter last year. By market sector, we have seen a slowdown in one of our product lines sold to the electronics industries.

 

Profit before tax for the first quarter amounted to £13.6m, compared with £15.1m last year.

 

The Group has increased its cost base compared with the comparable period last year, mainly by the addition of personnel to support its growing revenue and production demands, and investment in its research and development programmes. Headcount at the end of September 2011 was 2,745, an increase of 70 from the start of the financial year at 1st July 2011 and an increase of 538 over the 2,207 personnel at 30th September 2010.

 

Significant events and financial position

We are reviewing our healthcare business and have refocused part of the activities to a smaller number of projects, with some resources diverted to our metrology business.

 

The purchase of the Miskin premises, close to Cardiff in South Wales, was completed on 30th September 2011 and the Group also acquired premises for its Canadian and Italian subsidiaries. The aggregate cost of these acquisitions was £9.0m.

 

The Group continues to have a strong balance sheet with net cash balances at 30th September 2011 of £29.3m (30th June 2011 £34.6m).

 

I should like to thank our staff for their continuing efforts and support.

 

Outlook

It is still very early in the financial year and the Group traditionally has an order book of a little over one month's sales value. During the first quarter order intake has exceeded revenue and the Group has an order book of £31.9m at the end of September 2011.

 

Due to current uncertainties surrounding the global economy, the Board is closely monitoring the Group's costs and future recruitment strategy. Despite near-term challenges caused by the economic environment, we remain focused on positioning the Group for further long-term growth.

 

 

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

13th October 2011

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMJBMTMBMBBIB
Date   Source Headline
26th Jul 20187:00 amRNSFinal Results
25th Jul 20182:00 pmRNSDirectorate Change
4th Jul 20187:00 amRNSNotice of Results
13th Jun 20181:00 pmRNSDirector Declaration
24th May 20183:00 pmRNSVoting Arrangement
9th May 20187:00 amRNSTrading Statement
23rd Apr 20182:00 pmRNSDirector Declaration
9th Apr 20188:42 amRNSDirector/PDMR Shareholding
19th Mar 201812:00 pmRNSNotice of Investor Day
26th Jan 20181:27 pmRNSDirector/PDMR Shareholding
25th Jan 20185:03 pmRNSDirector/PDMR Shareholding
25th Jan 20187:00 amRNSHalf-year Report
24th Jan 20183:12 pmRNSChange in Directors' Responsibilities
11th Jan 20187:00 amRNSNotice of Results
20th Oct 20172:20 pmRNSResult of AGM
25th Aug 20177:00 amRNSAnnual Financial Report and Directorate Change
27th Jul 20177:00 amRNSFinal Results
10th Jul 201711:00 amRNSNotice of Results
26th May 20177:00 amRNSRemuneration policy 2017
10th May 20177:00 amRNSTrading Statement
31st Mar 20179:00 amRNSNotice of Investor Day
26th Jan 20177:00 amRNSHalf-year Report
9th Jan 201710:00 amRNSNotice of Results
13th Oct 20163:20 pmRNSResult of AGM
13th Oct 201610:54 amRNSTrading Statement
26th Aug 20169:00 amRNSAnnual Financial Report
27th Jul 20167:00 amRNSFinal Results
7th Jul 201610:00 amRNSNotice of Results
11th May 20167:00 amRNSTrading Statement
24th Mar 20167:00 amRNSTrading Statement
23rd Mar 201610:00 amRNSDate of Investor Day
25th Feb 20162:52 pmRNSDisclosure of Home Member State
28th Jan 20167:00 amRNSHalf Yearly Report
13th Jan 20161:39 pmRNSNotice of Results
15th Dec 20152:11 pmRNSDirector - change in responsibilities
15th Oct 20154:59 pmRNSResult of AGM
15th Oct 201510:31 amRNSTrading Statement
28th Aug 20157:00 amRNSAnnual Financial Report
29th Jul 20157:00 amRNSFinal Results
15th Jul 20152:06 pmRNSNotice of Results
18th May 201511:04 amRNSDirector/PDMR Shareholding
13th May 20157:00 amRNSTrading Statement
17th Mar 20157:43 amRNSDate of Investor day
29th Jan 20157:00 amRNSHalf Yearly Report
13th Jan 20153:08 pmRNSNotice of Results
6th Jan 20154:14 pmRNSTrading Statement
17th Nov 20147:00 amRNSStatement re Relationship agreement
11th Nov 20147:00 amRNSTrading Statement
27th Oct 20147:00 amRNSTrading Statement
16th Oct 20142:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.